Detailed definition
Female sexual dysfunction (FSD) is classified into desire disorders (hypoactive sexual desire disorder, HSDD), arousal disorders, orgasm disorders, and sexual pain disorders. The DSM-5 combined some of these into "female sexual interest/arousal disorder" and "genito-pelvic pain/penetration disorder." For diagnosis, symptoms must persist for 6+ months and cause clinically significant distress. In menopausal women, multiple mechanisms typically overlap: GSM-driven dyspareunia and reduced lubrication; declining ovarian testosterone (especially after surgical menopause); secondary effects of insomnia, hot flashes, and mood; relational and life-stage factors. Treatment is mechanism-targeted: vaginal estrogen, intravaginal DHEA, ospemifene, or moisturizers/lubricants for GSM; testosterone (off-label in the US) for HSDD with low androgen; flibanserin or bremelanotide for HSDD; couples therapy or sex therapy when relational factors dominate.
Why it matters in menopause
A meaningful share of "menopause" complaints reaching clinicians are actually downstream effects of treatable sexual pain or relational distress. Naming the components — pain, lubrication, desire, arousal, orgasm — makes it possible to treat them individually rather than calling everything "menopause."
Related terms
Sources
External references: Wikipedia.